logo
PROVIDERS
LABS
CROs
PAYORS
PATIENTS
ABOUT US
Schedule a Demo
Contact Us
Overview

Elevate Mental Health Care with AI-Driven Pharmacogenomics

Personalize psychiatric treatments, minimize trial-and-error, and enhance patient outcomes across your health system.
Schedule a Demo Contact us
Overview
Psychiatric disorders often require tailored approaches due to complex patient responses to medications. PGxAI's Psychiatry module (PGxEirene™) merges pharmacogenomics, machine learning, and real-world clinical data to streamline medication selection. By analyzing genetic markers and patient profiles, PGxAI reduces the guesswork in prescribing antidepressants, antipsychotics, and other psychiatric drugs—leading to faster therapeutic gains, fewer adverse effects, and greater patient satisfaction.
•
70+ psychiatric medications covered, from SSRIs to mood stabilizers and antipsychotics.
•
46 key genetic markers integrated to fine-tune dosage and treatment choices.
•
Real-time AI insights that adapt to each patient's evolving needs, boosting adherence and remission rates.
Key Highlights
Serving every stakeholder in healthcare
Schedule a Demo Contact Us
1
icon
Comprehensive Drug-Gene Analytics
Covers a broad range of antidepressants, antipsychotics, anxiolytics, and mood stabilizers, helping you select the right therapy the first time.
2
icon
Reduced Trial-and-Error
Genetic insights pinpoint optimal drug choices, minimizing the lengthy process of switching medications due to ineffective therapy or side effects.
3
icon
Enhanced Patient Engagement
Fewer adverse effects and quicker symptom relief encourage patients to stay committed to their treatment plans.
4
icon
Reimbursement-Friendly
Supported by recognized CPT codes, PGxAI testing makes personalized psychiatric care both clinically effective and economically viable.
Clinical Impact
Maximize Clinical Impact with PGxAI
Schedule a Demo Contact Us
Precision-Guided Therapy Optimization
PGxAI mines genotype, phenotype, and comorbidity data in real time to recommend the optimal drug–dose pair at the first prescription. By accounting for actionable allelic variants and metabolic phenotypes, it minimizes trial-and-error titration and sharply reduces severe drug–gene and drug–drug interactions.
Superior Patient Outcomes & Experience
Genomically informed prescribing lowers adverse-event rates, accelerates therapeutic response, optimizes co-administered medications and boosts adherence. Patients spend less time managing side effects and more time benefiting from treatment, enhancing both clinical endpoints and satisfaction metrics across specialties.
Demonstrable Value-Based Performance
Fewer complications, shorter lengths of stay, and reduced readmissions translate into measurable gains on CMS and private-payer quality dashboards. Institutions leveraging PGxAI can document higher quality scores and capture value-based reimbursement upside while lowering total cost of care.
Seamless Team Integration & Scalability
The platform embeds directly into leading EHRs and e-prescribing systems, delivering concise, guideline-aligned reports that support rapid decision-making for multidisciplinary teams. Standardized APIs and CDS hooks allow effortless expansion from pilot units to enterprise-wide deployment without workflow disruption.
Drug Categories
PGxAI supports comprehensive psychiatric treatments
Schedule a Demo Contact Us
icon
Antidepressants (SSRIs, SNRIs, TCAs):
Citalopram, Venlafaxine, Amitriptyline, etc.
Antipsychotics:
Risperidone, Quetiapine, Clozapine
Mood Stabilizers:
Lithium, Valproate, Lamotrigine
Anxiolytics & Hypnotics:
Benzodiazepines, Zolpidem, Buspirone
Substance Use Disorder Medications:
Naltrexone, Buprenorphin. Each recommendation is backed by robust AI modeling, factoring in genetic variants (e.g., CYP2C19, CYP2D6) and clinical research.
Case Study
Riverdale Mental Health Clinic
Schedule a Demo Contact Us
icon
Challenge
High discontinuation rates among patients on antidepressants, leading to multiple switches and frequent follow-ups.
icon
Solution
PGxAI integrated to identify optimal drug and dosage for each patient's genetic profile.
icon
Results
35% reduction in medication switches over 6 months, higher patient satisfaction, and improved clinical outcomes.
What's next
Ready to Shape the Future of Precision Medicine?
Empower your psychiatry team with a data-driven solution that accelerates treatment efficacy, curbs adverse events, and keeps patients engaged.
Request a Demo
Discover how PGxEirene™ can be integrated into your mental health services.
arrow icon